News | Image Guided Radiation Therapy (IGRT) | June 06, 2019

Provider search for innovative, patient-centric technologies for cancer diagnosis and treatment expected to drive growth through 2028

Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment

June 6, 2019 — Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in 2018, according to a recent study, suggesting increasing prevalence for the integrated technologies. According to the study from Fact.MR, the growth potential — projected at approximately a 20 percent compound annual growth rate (CAGR) through 2028 — can be attributed to burgeoning adoption of innovative technologies in cancer diagnosis and treatment, alongside growing focus on patient-centric care.

The study assesses macro- and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shifts in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

“Leading cancer research institutes are exploring the potential for MRI in radiation therapy in order to enhance the efficiency and precision of existing cancer treatments. However, integrating MRI technology, which uses a magnetic field to produce images, with an all-metal linear accelerator [linac] in radiation therapy devices requires exceptional technological expertise and a strong international consortium. Currently, Elekta and Viewray are the only two companies that have a strong foothold in the MRI-guided radiation therapy systems market, and it may be a while until new entrants make foray into the market,” the study authors said.

The study opines that hospitals, with more than 51 percent revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019. Opportunities abound for MRI-guided radiation therapy system developers, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT.

The study also finds that radiotherapy centers are adopting technologically advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective. Market players are focusing on building a successful consortium with the help of physicians, clinicians, and original equipment manufacturers (OEMs), to tap into opportunities in radiation therapy centers.

The study opines that the increasing healthcare expenditure in the U.S. will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was more than $10,000 in the U.S., recording an increase of nearly 4 percent over 2016, according to studies. In addition, what the Fact.MR study calls an alarming rise in the prevalence of cancer in the U.S. will be reflected in a significant demand for MRI-guided radiation therapy systems in North America.

According to the study, North America accounted for 45 percent of sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region are expected to create new opportunities for market players.

Download the full report here.

For more information: www.factmr.com

 

Related MRI-guided Radiotherapy Content

VIDEO: Walk Through of the MRI Radiotherapy System at Henry Ford Hospital

Elekta Unity MR-Linac Earns FDA Clearance

VIDEO: Clinical Use of the ViewRay MRIdian Linac System at Henry Ford


Related Content

Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
News | Contrast Media

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...

Time September 21, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
Sponsored Content | Case Study | Radiology Imaging | By Tim Hodson

In June, the Philips Radiology Experience Tour hit the road to provide healthcare professionals with an opportunity to ...

Time September 19, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Christine Book

The world of medical imaging is marking a significant milestone in 2023: the 50th anniversary of magnetic resonance ...

Time September 19, 2023
arrow
News | Lung Imaging

September 11, 2023 — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced magnetic ...

Time September 11, 2023
arrow
Subscribe Now